Search

everythinglearnresearchcommunity

for

Search:↓

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

JAK inhibitors offer new hope for treating severe alopecia areata.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Tofacitinib may effectively treat folliculitis decalvans.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Iressa often causes skin issues like acne and dryness in lung cancer patients.